Nevertheless, more lines of evidence indicated that activation of Wnt5a-mediated signaling was associated with malignant capacity of many cancer types, which exhibited paradoxical effects on tumorigenicity, resistance to therapeutic agents, and/or metastasis in a cancer cell type-dependent manner [47, 51, 53]. Here, WNT5A is linked to cancer.